Benefits of abciximab accrue in the full spectrum of coronary interventional patients: Insights from the EPILOG trial

Journal Article

Full Text

Duke Authors

Cited Authors

  • Tcheng, JE; Lincoff, AM; Miller, DP; Booth, JE; Rund, MM; Cabot, CF; Weisman, HF; Califf, RM; Topol, EJ

Published Date

  • February 1997

Published In

Volume / Issue

  • 29 / 2

Start / End Page

  • 9931 - 9931

International Standard Serial Number (ISSN)

  • 0735-1097